The FDA has approved Uceris (budesonide) extended release tablets, from Santarus, for the induction of remission in patients with active,...
Actavis plc confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval to market...
Salix Pharmaceuticals announced the peer-reviewed publication of a study in the Journal of Crohn's & Colitis evaluating the safety and...
Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. announced that they have entered into a definitive agreement under which Valeant...
Cosmo Pharmaceuticals received a communication from the Dutch Regulatory Agency (MEB) declining the approval of Cortiment(budesonide with MMX technology), indi�ca�ted...